![Improvement of Restless Legs Syndrome by Varenicline as Antismoking Treatment | Journal of Clinical Sleep Medicine Improvement of Restless Legs Syndrome by Varenicline as Antismoking Treatment | Journal of Clinical Sleep Medicine](https://jcsm.aasm.org/cms/asset/3d3b01e2-da7c-443f-8a02-1ddae4293825/jcsm.9.10-1089.t01.jpg)
Improvement of Restless Legs Syndrome by Varenicline as Antismoking Treatment | Journal of Clinical Sleep Medicine
![Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation - ScienceDirect Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1389945716000563-sleep3013-fig-0001.jpg)
Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation - ScienceDirect
Studying Medicine on Twitter: "Updated guidelines for mgt of restless legs syndrome (RLS) - For chronic persistent RLS in adults despite appropriate iron supplementation —> first-line therapy with alpha-2-delta calcium channel ligand (
![Studying Medicine on Twitter: "Updated guidelines for mgt of restless legs syndrome (RLS) - For chronic persistent RLS in adults despite appropriate iron supplementation —> first-line therapy with alpha-2-delta calcium channel ligand ( Studying Medicine on Twitter: "Updated guidelines for mgt of restless legs syndrome (RLS) - For chronic persistent RLS in adults despite appropriate iron supplementation —> first-line therapy with alpha-2-delta calcium channel ligand (](https://pbs.twimg.com/media/FD6nwrjX0AQcfZP.jpg:large)